Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer

Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer

Posterior reversible encephalopathy syndrome (PRES) is an increasingly recognizable neuro-clinical syndrome. Clinical and neurological manifestations of PRES include hypertension, headache, encephalopathy, seizures, and symmetrical white matter changes on brain MRI. Most common precipitants of PRES...

Full description

Bibliographic Details
Main Authors: Mohsin Hamid, Ali Ghani, Ida Micaily, Usman Sarwar, Bilal Lashari, Faizan Malik
Format: Article
Language:English
Published: Greater Baltimore Medical Center 2018-05-01
Series:Journal of Community Hospital Internal Medicine Perspectives
Subjects:
PRES
RPLS
BRES
VEGF
Bevacizumab
FOLFOX
angiogenesis
Online Access:http://dx.doi.org/10.1080/20009666.2018.1478563

Internet

http://dx.doi.org/10.1080/20009666.2018.1478563

Similar Items